Literature DB >> 35243539

Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype.

Sho Yamazawa1, Tetsuo Ushiku2.   

Abstract

Carcinosarcoma of the stomach is a rare neoplasm characterized by the presence of both epithelial and mesenchymal malignant components. We describe four examples with a focus on the characterization of the epithelial components and the histogenetic implications for this unique tumor. All patients were men aged 40-79 years. All patients developed metastatic disease, and three of them died 4-19 months after the diagnosis. Sarcomatous elements included poorly differentiated spindle cell sarcoma without distinctive differentiation (n = 4), chondrosarcoma (n = 2), and rhabdomyosarcoma (n = 1). In two cases, the sarcomatous component was recognized only in metastatic lesions. Notably, carcinomatous components were characterized by multilineage and primitive cellular differentiation, including carcinoma with enteroblastic (n = 4), hepatoid (n = 3), yolk sac tumor-like (n = 1), trophoblastic (n = 1), and neuroendocrine (n = 1) differentiation, as well as conventional tubular adenocarcinoma (n = 4). On immunohistochemistry, all four cases showed varying degrees of positive expression of primitive phenotypic markers, including alpha-fetoprotein (AFP), glypican-3, or SALL4. All tumors showed mutant patterns of p53 staining, exhibiting either diffusely positive or completely negative staining. On the basis of these findings, at least some gastric carcinosarcomas are likely to be derived from carcinoma with a primitive phenotype, including AFP-producing adenocarcinoma. Our observations suggest that sarcomatous differentiation, as well as multilineage differentiation of epithelial components, may represent increased cellular plasticity of gastric carcinoma with a primitive phenotype.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alpha-fetoprotein; Carcinosarcoma; Gastric cancer; Glypican-3; Primitive phenotype; SALL4

Mesh:

Substances:

Year:  2022        PMID: 35243539     DOI: 10.1007/s00428-022-03307-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  6 in total

1.  HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.

Authors:  Masakazu Fujimoto; Ibu Matsuzaki; Masaru Nishino; Yoshifumi Iwahashi; Kenji Warigaya; Fumiyoshi Kojima; Kazuo Ono; Shin-Ichi Murata
Journal:  J Clin Pathol       Date:  2018-01-05       Impact factor: 3.411

2.  Integrated Molecular Characterization of Uterine Carcinosarcoma.

Authors:  Andrew D Cherniack; Hui Shen; Vonn Walter; Chip Stewart; Bradley A Murray; Reanne Bowlby; Xin Hu; Shiyun Ling; Robert A Soslow; Russell R Broaddus; Rosemary E Zuna; Gordon Robertson; Peter W Laird; Raju Kucherlapati; Gordon B Mills; John N Weinstein; Jiashan Zhang; Rehan Akbani; Douglas A Levine
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

3.  HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

Authors:  Angela N Bartley; Mary Kay Washington; Carol Colasacco; Christina B Ventura; Nofisat Ismaila; Al B Benson; Alfredo Carrato; Margaret L Gulley; Dhanpat Jain; Sanjay Kakar; Helen J Mackay; Catherine Streutker; Laura Tang; Megan Troxell; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2016-11-14       Impact factor: 44.544

4.  Gastric carcinosarcoma with rhabdomyosarcomatous differentiation: a case report and review.

Authors:  Masashi Fujiie; Manabu Yamamoto; Kenichi Taguchi; Ayako Iwanaga; Kippei Ohgaki; Akinori Egashira; Kazuhito Minami; Yasushi Toh; Yoshinao Oda; Takeshi Okamura
Journal:  Surg Case Rep       Date:  2016-06-02

5.  Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.

Authors:  Kenichiro Furukawa; Masahiro Niihara; Takuya Kawata; Shuhei Mayanagi; Yasuhiro Tsubosa
Journal:  Surg Case Rep       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.